Featured Research

from universities, journals, and other organizations

MRIs help predict which atrial fibrillation patients will benefit from catheter ablation

Date:
February 4, 2014
Source:
Loyola University Health System
Summary:
A new type of contrast MRI can predict which heart patients with atrial fibrillation are most likely to benefit from a treatment called catheter ablation, according to a landmark multi-center study published.

A new type of contrast MRI can predict which heart patients with atrial fibrillation are most likely to benefit from a treatment called catheter ablation, according to a landmark multi-center study published in the Journal of the American Medical Association.

Loyola University Medical Center had the second highest enrollment in the international study, contributing 15 percent of the patients. David Wilber, MD, director of Loyola's Division of Cardiology and Section of Clinical Electrophysiology, is second author. First author is Nassir Marrouche, MD of the University of Utah School of Medicine.

Atrial fibrillation, or A-fib, is the most common type of arrhythmia (irregular heartbeat). It's caused by erratic electrical signals in the heart. When medications don't work, A-fib often can be controlled with catheter ablation, in which a catheter burns away heart tissue responsible for the erratic signals. Catheter ablation does not work for all patients, however, and there has not been a reliable way to predict which ones will benefit.

Researchers enrolled 329 patients from 15 centers in the United States, Europe and Australia. Each underwent a catheter ablation. Less than 30 days before their ablations, the patients also underwent a new type of imaging test called delayed enhancement-magnetic resonance imaging (DE-MRI) of the upper chamber of the heart (left atrium). The imaging shows scarring of the wall of the left atrium called atrial fibrosis.

Researchers excluded 69 patients because their DE-MRIs were of insufficient quality or because researchers lost track of them during follow-up. That left 260 patients. After 475 days of follow up, patients with the least amount of scarring had significantly higher ablation success rates.

The pre-ablation DE-MRIs showed the amount of scarring in the left atrium, one of the heart's two upper chambers. Scarring ranged from Stage 1 (covering less than 10 percent of the atrial wall) to Stage 4 (covering more than 30 percent of the atrial wall).

After 475 days of follow up, 85 percent of patients with the least-severe Stage 1 scarring had experienced no recurrent arrhythmias. The success rate dropped to 64 percent for patients with Stage 2 scarring, 54 percent for patients with Stage 3 scarring and only 31 percent for patients with the most severe Stage 4 scarring.

"Catheter ablation is a very effective treatment for atrial fibrillation, but it can't cure everyone," Wilber said. "The findings from this study suggest there may be patients whose scarring is so advanced that ablation in its current form is much less likely to be effective as a single procedure. In such cases, patients, in consultation with their physicians, may decide to forgo ablation, or be prepared to have more than one procedure to control the arrhythmia."

Patients unlikely to benefit from ablation still could be treated with medications, and in some circumstances with pacemakers, Wilber added.

Loyola is the only center in the Midwest that offers this new type of DE-MRI for A-fib patients. DE-MRI uses sophisticated imaging techniques to acquire and process images. "DE-MRI enables us to look at not just the heart size and function, but also structural changes in the heart, such as fibrosis, that can better inform treatment decisions," said Mushabbar Syed, MD, Loyola's Director of Cardiovascular Imaging. These advanced imaging technologies, along with expert arrhythmia specialists, make Loyola a unique center for A-fib patients.

The study also suggests that earlier treatment may be beneficial, since the longer a patient experiences A-fib, the more scarring the patient is likely to have. But this would need to be confirmed by further studies, Wilber said.

Patients in the study also underwent DE-MRIs 90 days after their catheter ablations. These follow-up scans showed physicians how effective the ablations had been in burning troublesome scar tissue. Such findings could help guide physicians if and when additional ablations are necessary, Wilber said.

More than 2 million Americans have atrial fibrillation, and there are about 160,000 new cases each year. The number is increasing, due in part to the aging population and the obesity epidemic. A-fib is the most common form of irregular heartbeat. Electrical signals, which regulate the heartbeat, become erratic. Instead of beating regularly, the upper chambers of the heart quiver. Not all the blood gets pumped out, so clots can form. A-fib can lead to strokes and heart failure. A-fib symptoms include heart palpitations, dizziness, chest pain, fatigue, shortness of breath, fainting and lightheadedness.


Story Source:

The above story is based on materials provided by Loyola University Health System. Note: Materials may be edited for content and length.


Journal Reference:

  1. Nassir F. Marrouche, David Wilber, Gerhard Hindricks, Pierre Jais, Nazem Akoum, Francis Marchlinski, Eugene Kholmovski, Nathan Burgon, Nan Hu, Lluis Mont, Thomas Deneke, Mattias Duytschaever, Thomas Neumann, Moussa Mansour, Christian Mahnkopf, Bengt Herweg, Emile Daoud, Erik Wissner, Paul Bansmann, Johannes Brachmann. Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation. JAMA, 2014; 311 (5): 498 DOI: 10.1001/jama.2014.3

Cite This Page:

Loyola University Health System. "MRIs help predict which atrial fibrillation patients will benefit from catheter ablation." ScienceDaily. ScienceDaily, 4 February 2014. <www.sciencedaily.com/releases/2014/02/140204162210.htm>.
Loyola University Health System. (2014, February 4). MRIs help predict which atrial fibrillation patients will benefit from catheter ablation. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/02/140204162210.htm
Loyola University Health System. "MRIs help predict which atrial fibrillation patients will benefit from catheter ablation." ScienceDaily. www.sciencedaily.com/releases/2014/02/140204162210.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins